Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy
Author(s) -
Ortal Barel,
May Christine V. Malicdan,
Bruria BenZeev,
Judith Kandel,
Hadass PriChen,
Joshi Stephen,
Inês Gomes Castro,
Jeremy Metz,
Osama Atawa,
Sharon Moshkovitz,
Esther Ganelin,
Iris Barshack,
Sylvie PolakCharcon,
Dvora Nass,
Dina MarekYagel,
Ninette Amariglio,
Nechama Shalva,
Thierry Vilboux,
Carlos R. Ferreira,
Ben PodeShakked,
Gali Heimer,
Chen Hoffmann,
Tal Yardeni,
Andreea Nissenkorn,
Camila Avivi,
Eran Eyal,
Nitzan Kol,
Efrat G. Saar,
Douglas C. Wallace,
William A. Gahl,
Gideon Rechavi,
Michael Schrader,
David M. Eckmann,
Yair Anikster
Publication year - 2017
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awx002
Subject(s) - biology , mitochondrion , kinesin , microbiology and biotechnology , gene , microtubule , genetics
Cellular distribution and dynamics of mitochondria are regulated by several motor proteins and a microtubule network. In neurons, mitochondrial trafficking is crucial because of high energy needs and calcium ion buffering along axons to synapses during neurotransmission. The trafficking kinesin proteins (TRAKs) are well characterized for their role in lysosomal and mitochondrial trafficking in cells, especially neurons. Using whole exome sequencing, we identified homozygous truncating variants in TRAK1 (NM_001042646:c.287-2A > C), in six lethal encephalopathic patients from three unrelated families. The pathogenic variant results in aberrant splicing and significantly reduced gene expression at the RNA and protein levels. In comparison with normal cells, TRAK1-deficient fibroblasts showed irregular mitochondrial distribution, altered mitochondrial motility, reduced mitochondrial membrane potential, and diminished mitochondrial respiration. This study confirms the role of TRAK1 in mitochondrial dynamics and constitutes the first report of this gene in association with a severe neurodevelopmental disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom